Cell and gene therapy logistics market analysis with future outlook
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Cell And Gene Therapy Supply Chain/Logistics Market During 2026–2030?
The cell and gene therapy supply chain/logistics market size has experienced rapid growth in recent years. This market is forecast to expand from $1.58 billion in 2025 to $1.78 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.2%. Key factors contributing to its historical growth include the increasing complexity of cell and gene therapy logistics, the early adoption of cryogenic shipping solutions, the expansion of centralized manufacturing models, a growing regulatory focus on traceability, and the rising use of specialized logistics providers.
The cell and gene therapy supply chain/logistics market size is anticipated to undergo substantial growth in the coming years, projected to reach $2.81 billion by 2030, with a compound annual growth rate (CAGR) of 12.1%. This expansion during the forecast period is fueled by the increasing commercialization of personalized therapies, a rising demand for end-to-end supply chain visibility, the enlargement of global therapy distribution networks, the growing adoption of cloud-based logistics platforms, and increased investments in smart cold chain infrastructure. Prominent trends for the forecast period include the expansion of integrated cold chain management platforms, the growing acceptance of real-time tracking and traceability systems, the increasing utilization of cryogenic logistics solutions, the wider integration of patient-centric supply chain models, and an enhanced focus on chain of custody compliance.
Access Your Free Sample Report For In-Depth Market Analysis:
What Significant Factors Are Influencing The Cell And Gene Therapy Supply Chain/Logistics Market Expansion?
The growing demand for cell and gene therapies is a primary catalyst for the cell and gene therapy supply chain or logistics market. These advanced medical treatments modify cells or genes to treat diseases, providing potential breakthroughs for conditions previously considered untreatable. Crucially, these cell and gene therapies require specific temperature and storage conditions, which are effectively managed by supply chain and logistics services, covering processes from sourcing to distribution and storage. For instance, in 2023, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, reported a 10% increase in the number of gene therapies in Phase III clinical trials in Q3 2023, representing the first quarterly rise since Q3 2022. Thus, the escalating need for cell and gene therapies actively drives the cell and gene therapy supply chain or logistics market forward.
Which Segment Categories Are Included In The Cell And Gene Therapy Supply Chain/Logistics Market Segment Analysis?
The cell and gene therapy supply chain/logistics market covered in this report is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
Subsegments:
1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking, Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation
What Trends Are Affecting The Direction Of The Cell And Gene Therapy Supply Chain/Logistics Market?
The cell and gene therapy supply chain/logistics markets are witnessing a significant trend: the growing appeal of modern technology platforms. Prominent companies within this market are developing advanced technology platforms for cell and gene therapies to uphold their market position. For example, in April 2023, AmerisourceBergen Corporation., a US-based healthcare company specializing in cell and gene therapy supply chain logistics, unveiled the Cell and Gene Therapy (CGT) Integration Hub. This Cell and Gene Therapy (CGT) Integration Hub is driven by AmerisourceBergen’s innovative customer relationship management (CRM) system. It offers seamless integration into biopharma platforms to provide improved monitoring of the development and delivery processes for cell and gene therapies.
Who Are The Active Companies Shaping The Cell And Gene Therapy Supply Chain/Logistics Market?
Major companies operating in the cell and gene therapy supply chain/logistics market are AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.
Get The Full Cell And Gene Therapy Supply Chain/Logistics Market Report:
Which Geographic Region Dominates The Cell And Gene Therapy Supply Chain/Logistics Market?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2025. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cell And Gene Therapy Supply Chain/Logistics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Cell And Gene Therapy Supply Chain/Logistics Market 2026, By The Business Research Company
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Cell And Gene Therapy Manufacturing Services Market 2026
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
